Anti-Filamin C (phospho S2113) antibody (ab20485)


  • Product nameAnti-Filamin C (phospho S2113) antibody
    See all Filamin C primary antibodies
  • Description
    Rabbit polyclonal to Filamin C (phospho S2113)
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat, Chimpanzee
  • Immunogen

    Synthetic peptide corresponding to Filamin C. The antiserum was produced against a chemically synthesized phosphopeptide derived from the region of human Filamin C that contains serine 2146.

  • Positive control
    • C2C12, HeLa, HEK293 + EGF.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferPreservative: 0.05% Sodium Azide
    Constituents: 50% Glycerol, PBS(without Mg2+ and Ca2+), 1mg/ml BSA (IgG, protease free) as a carrier. pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesPurified from rabbit serum by sequential epitope-specific chromatography. The antibody has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated Filamin C. The final product is generated by affinity chromatography using a Filamin C-derived peptide that is phosphorylated at serine 2113.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab20485 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000. Predicted molecular weight: 291 kDa.


  • RelevanceFLNC is a muscle-specific filamin, which plays a central role in muscle cells, probably by functioning as a large actin-cross-linking protein. May be involved in reorganizing the actin cytoskeleton in response to signaling events, and may also display structural functions at the Z-disks in muscle cells. Defects in FLNC are the cause of autosomal dominant filaminopathy. Myofibrillar myopathy (MFM) is a neuromuscular disorder, usually with an adult onset, characterized by focal myofibrillar destruction and pathological cytoplasmic protein aggregations. Autosomal dominant filaminopathy is a form of MFM characterized by morphological features of MFM and clinical features of a limb-girdle myopathy. A heterozygous nonsense mutation which segregates with the disease, has been identified in the FLNC gene.
  • Cellular localizationCytoplasmic
  • Database links
  • Alternative names
    • ABPL antibody
    • Actin binding like protein antibody
    • FIlamin 2 antibody
    • Filamin C antibody
    • FLN2 antibody
    • Gamma filamin antibody
    see all

Anti-Filamin C (phospho S2113) antibody images

  • All lanes : Anti-Filamin C (phospho S2113) antibody (ab20485) at 1/1000 dilution

    Lane 1 : HeLa cell lysate + Lambda phosphatase
    Lane 2 : HeLa cell lysate
    Lane 3 : HeLa cell lysate with a non-phosphorylated peptide corresponding to the immunogen
    Lane 4 : HeLa cell lysate with a generic phosphoserine-containing peptide
    Lane 5 : HeLa cell lysate with a phosphopeptide corresponding to Filamin C (phospho S2113)
    Lane 6 : Mouse myoblast cell lysate

    Predicted band size : 291 kDa

    Right panel: Lysates from HEK293 cells untreated (left lanes) or treated with EGF (right lanes). Western blotting was performed using the Filamin C (phospho S2113) antibody (upper blot) or an antibody recognizing total filamin protein (lower blot).

References for Anti-Filamin C (phospho S2113) antibody (ab20485)

ab20485 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab20485.
Please use the links above to contact us or submit feedback about this product.